Senior Director, Commercialization FP&A

About this role

Revolution Medicines is a global, commercial-state oncology company dedicated to discovering, developing and delivering innovative medicines for patients with RAS-addicted cancers. Leveraging its differentiated RAS(ON) tri-complex inhibitor platform, the company is advancing a broad, integrated portfolio of oral RAS(ON) inhibitors designed to directly target the active, cancer-driving state of RAS. Founded on rigorous scientific inquiry and a willingness to challenge long-held assumptions, Revolution Medicines is committed to changing the trajectory of disease for patients with RAS-addicted cancers worldwide.

Our people are united by a shared way of working: follow the science, challenge assumptions, act with urgency and hold ourselves to a high standard of rigor—all in service of patients. The Opportunity: Revolution Medicines is seeking a Senior Director of Commercialization FP&A to join our growing Finance team. The Senior Director of Commercialization FP&A will act as the key financial business partner for our growing Global Commercialization organization and support Global Commercial & Access, Global Medical Affairs, and US Commercial teams.

This role reports to the VP, FP&A. Responsibilities include: Build and maintain strong cross-functional business partnerships to forecast and track activities by embedding finance into decision-making processes. Collaborate with various levels of management to gather, analyze, summarize, and prepare operating budgets and financial forecasts during planning cycles (e.g., annual budget, mid-year re-forecast, launch planning, etc.).

Provide financial direction to key stakeholders with influence with proactive recommendations, supported by robust financial analysis and insightful delivery. Develop and prepare monthly internal financial management reporting packages and commercialization profit/loss reports for the global and US organizations, closely working with ex-US Finance colleagues to streamline overall approach and business rules across different regions.

Oversee monthly variance analysis of actuals to budget, investigate any major discrepancies, and articulate key business drivers. Support ad hoc analyses and special projects, providing timely and accurate financial insights to support successful commercialization of medicines upon regulatory approval. Help drive process improvements and efficiencies in areas of financial planning, financial analysis, and production of reporting packages.